Finance

Lists
Why is PLSE up 2.57%?
Dive Deeper
PLSE:NASDAQ
Pulse Biosciences Inc
$45.55
+2.57%
(+1.14) 1D
$45.50
-0.11% (-0.050)
After hours
Closed: Nov 20, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PLSE...
Open
$44.00
High
$46.06
Low
$43.72
Mkt. cap
3.35B
Avg. vol.
407.61K
Volume
466.85K
52-wk high
$58.94
52-wk low
$12.70
EPS
-$1.21
Beta
1.65
Shares outstanding
73.55M
No. of employees
116
Open
$44.00
High
$46.06
Low
$43.72
Mkt. cap
3.35B
Avg. vol.
407.61K
Volume
466.85K
52-wk high
$58.94
52-wk low
$12.70
EPS
-$1.21
Beta
1.65
Shares outstanding
73.55M
No. of employees
116
News stories
From web sources and news partners
About Pulse Biosciences Inc
CEO-
Employees116
Founded2014
HeadquartersHayward, California, United States
SectorHealth Care
IndustryMedical device
Analyst ratings
Based on 5 analysts giving stock ratings to PLSE in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for PLSE in the last 3 months.
Highest
Current $45.55
$74.00 (+62.46%)
Average
$68.40 (+50.16%)
Lowest
$60.00 (+31.72%)
Analyst
Recommendation
Action
Price target
Projected
Date
Marie Thibault
BTIG
Buy
Reiterated
$70.00
+53.7%
11/05/2026
William Plovanic
Canaccord Genuity
Buy
Maintained
$74.00
+62.5%
11/06/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
$65.00
+42.7%
11/06/2026
Suraj Kalia
Oppenheimer
Buy
Maintained
$60.00
+31.7%
10/13/2026
Keith Hinton
Freedom Capital Markets
Buy
Initiated
$73.00
+60.3%
09/09/2026
Michael Matson
Needham
Buy
Initiated
$58.00
+27.3%
08/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
264.00K
401.00K
434.00K
395.00K
Cost of goods sold
260.00K
370.00K
273.00K
191.00K
Cost of revenue
260.00K
370.00K
273.00K
191.00K
Research and development expenses
10.93M
12.59M
16.98M
16.85M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.33M
6.59M
8.46M
7.65M
Operating expense
18.26M
19.18M
25.43M
24.50M
Total operating expenses
18.52M
19.55M
25.71M
24.69M
Operating income
-18.25M
-19.15M
-25.27M
-24.29M
Other non operating income
-5.00K
-24.00K
15.00K
36.00K
EBT including unusual items
-17.43M
-18.58M
-24.66M
-23.05M
EBT excluding unusual items
-17.43M
-18.58M
-24.66M
-23.05M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-17.43M
-18.58M
-24.66M
-23.05M
Net profit margin
-6,603.41%
-4,633.67%
-5,681.34%
-5,835.70%
Earnings per share
-0.18
-0.24
-0.28
-0.24
Interest and investment income
825.00K
593.00K
600.00K
1.20M
Interest expense
-
-
-
-
Net interest expenses
825.00K
593.00K
600.00K
1.20M
Depreciation and amortization charges
-
-
-
-
EBITDA
-17.99M
-18.90M
-25.02M
-24.03M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps